NCT01988571 2022-01-04
Preventing Anthracycline Cardiovascular Toxicity With Statins (PREVENT)
Wake Forest University Health Sciences
Phase 2 Completed
Clinical Trials
5 trialsNCT01527045 2020-01-02
Donor Atorvastatin Treatment in Preventing Severe Acute GVHD After Nonmyeloablative Peripheral Blood Stem Cell Transplant in Patients With Hematological Malignancies
Fred Hutchinson Cancer Center
Phase 2 Completed
NCT01491958 2018-01-23
Safety & Efficacy of Atorvastatin for Prophylaxis of Acute Graft Versus Host Disease in Patients With Hematological Malignancies HLA- Donor Hematopoietic Stem Cell Transplantation
Ohio State University Comprehensive Cancer Center
Phase 2 Completed
NCT00185731 2017-12-02
Phase 2 Study of Atorvastatin Safety and Antitumor Effects in Non-Hodgkin's Lymphoma
Stanford University
Phase 2 Completed
NCT01733953 2016-12-14
Statin Therapy in Young Adult Survivors of Childhood Cancer
University of Minnesota
Phase 2 Completed